127 related articles for article (PubMed ID: 38914584)
1. Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia.
Salustiano-Bandeira ML; Moreira-Aguiar A; Pereira-Martins DA; Coelho-Silva JL; Weinhäuser I; França-Neto PL; Lima AS; Lima AS; Baccarin AR; Silva FB; de Melo MA; Niemann FS; Nardinelli L; Ortiz Rojas CA; Duarte BK; Araujo AS; Azevedo EA; Morais CN; Figueiredo-Pontes LL; Schuringa JJ; Huls G; Bendit I; Rego EM; Olalla Saad ST; Traina F; Bezerra MA; Lucena-Araujo AR
Blood Cancer J; 2024 Jun; 14(1):102. PubMed ID: 38914584
[No Abstract] [Full Text] [Related]
2. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
Lucena-Araujo AR; Kim HT; Thomé C; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Glória AB; Chauffaille Mde L; Athayde M; Chiattone CS; Mito I; Bendlin R; Souza C; Bortolheiro C; Coelho-Silva JL; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Blood; 2015 Nov; 126(20):2302-6. PubMed ID: 26429976
[TBL] [Abstract][Full Text] [Related]
3. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
4. Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells.
Chakraborty J; Banerjee S; Ray P; Hossain DMS; Bhattacharyya S; Adhikary A; Chattopadhyay S; Das T; Sa G
J Biol Chem; 2010 Oct; 285(43):33104-33112. PubMed ID: 20675383
[TBL] [Abstract][Full Text] [Related]
5. Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma.
Hassan HM; Varney ML; Jain S; Weisenburger DD; Singh RK; Dave BJ
Leuk Lymphoma; 2014 Dec; 55(12):2924-31. PubMed ID: 24660851
[TBL] [Abstract][Full Text] [Related]
6. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.
Müller M; Schilling T; Sayan AE; Kairat A; Lorenz K; Schulze-Bergkamen H; Oren M; Koch A; Tannapfel A; Stremmel W; Melino G; Krammer PH
Cell Death Differ; 2005 Dec; 12(12):1564-77. PubMed ID: 16195739
[TBL] [Abstract][Full Text] [Related]
7. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.
Zitterbart K; Zavrelova I; Kadlecova J; Spesna R; Kratochvilova A; Pavelka Z; Sterba J
Acta Neuropathol; 2007 Dec; 114(6):641-50. PubMed ID: 17912537
[TBL] [Abstract][Full Text] [Related]
8. Relative expression of TAp73 and ΔNp73 isoforms.
Conforti F; Yang AL; Agostini M; Rufini A; Tucci P; Nicklison-Chirou MV; Grespi F; Velletri T; Knight RA; Melino G; Sayan BS
Aging (Albany NY); 2012 Mar; 4(3):202-5. PubMed ID: 22388545
[TBL] [Abstract][Full Text] [Related]
9. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.
Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.
Lai J; Nie W; Zhang W; Wang Y; Xie R; Wang Y; Gu J; Xu J; Song W; Yang F; Huang G; Cao P; Guan X
Oncotarget; 2014 Aug; 5(16):6909-22. PubMed ID: 25071010
[TBL] [Abstract][Full Text] [Related]
11. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
Jung YS; Qian Y; Chen X
J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
[TBL] [Abstract][Full Text] [Related]
12. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
[TBL] [Abstract][Full Text] [Related]
13. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
[TBL] [Abstract][Full Text] [Related]
14. Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.
Zhang Y; Yan W; Jung YS; Chen X
J Biol Chem; 2012 May; 287(21):17746-17753. PubMed ID: 22457351
[TBL] [Abstract][Full Text] [Related]
15. DEC1 coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73 expression.
Qian Y; Zhang J; Jung YS; Chen X
PLoS One; 2014; 9(1):e84015. PubMed ID: 24404147
[TBL] [Abstract][Full Text] [Related]
16. DeltaNp73 transcription factors modulate cell survival and tumor development.
Ravni A; Tissir F; Goffinet AM
Cell Cycle; 2010 Apr; 9(8):1523-7. PubMed ID: 20372082
[TBL] [Abstract][Full Text] [Related]
17. Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.
Becker K; Pancoska P; Concin N; Vanden Heuvel K; Slade N; Fischer M; Chalas E; Moll UM
Int J Oncol; 2006 Oct; 29(4):889-902. PubMed ID: 16964385
[TBL] [Abstract][Full Text] [Related]
18. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
19. Expression of TAP73 and DeltaNP73 in malignant gliomas.
Ugur H; Sayan AE; Ozdamar SO; Kanpolat Y; Ozturk M
Oncol Rep; 2004 Jun; 11(6):1337-41. PubMed ID: 15138575
[TBL] [Abstract][Full Text] [Related]
20. Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.
Benosman S; Meng X; Von Grabowiecki Y; Palamiuc L; Hritcu L; Gross I; Mellitzer G; Taya Y; Loeffler JP; Gaiddon C
J Biol Chem; 2011 Dec; 286(50):43013-25. PubMed ID: 22002055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
